Literature DB >> 10684708

Expression and clinical significance of apolipoprotein D in epithelial ovarian carcinomas.

J Vázquez1, L González, A Merino, F Vizoso.   

Abstract

OBJECTIVE: Apolipoprotein D is a protein component of the human plasma lipid transport system but is also associated with a more favorable prognosis in women with breast cancer. This retrospective study was undertaken to examine the tumoral expression of apolipoprotein D in epithelial ovarian cancer and to analyze the possible correlation with tumor and patient characteristics as well as androgen receptors and their prognostic significance.
METHODS: Immunohistochemical evaluation was used to examine apolipoprotein D expression in paraffin blocks from 68 epithelial ovarian carcinomas.
RESULTS: A total of 18 (26.4%) tumors stained positively. No significant correlation was found between apolipoprotein D expression and patient or tumor characteristics and androgen receptor status. However, apolipoprotein D expression was significantly associated with prognosis in patients with residual tumor greater than 1 cm. Thus, patients with apolipoprotein-D-negative tumors had a poorer overall survival than those with apolipoprotein-D-positive tumors (P = 0.039). In addition, multivariate analysis demonstrated that apolipoprotein D expression was an independent prognostic factor with initial tumor size in this group of patients (P = 0.005).
CONCLUSIONS: Our results led us to consider the existence of apolipoprotein D expression by a significative percentage of ovarian carcinomas, and this protein expression might be of clinical usefulness for identifying lesions with different evolution. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684708     DOI: 10.1006/gyno.1999.5678

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

Authors:  Emily N Manderson; Anne-Marie Mes-Masson; Jaroslav Novak; Peter D Lee; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors:  Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal:  J Proteome Res       Date:  2011-11-18       Impact factor: 4.466

3.  Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions.

Authors:  Raquel Bajo-Grañeras; Jesús Crespo-Sanjuan; Rosa M García-Centeno; José Antonio Garrote-Adrados; Gabriel Gutierrez; Manuel García-Tejeiro; Beatriz Aguirre-Gervás; María D Calvo-Nieves; Rosa Bustamante; Maria D Ganfornina; Diego Sanchez
Journal:  Int J Colorectal Dis       Date:  2013-01-08       Impact factor: 2.571

Review 4.  Apolipoproteins and cancer.

Authors:  Liwen Ren; Jie Yi; Wan Li; Xiangjin Zheng; Jinyi Liu; Jinhua Wang; Guanhua Du
Journal:  Cancer Med       Date:  2019-10-01       Impact factor: 4.452

5.  Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.

Authors:  Wenxin Liu; Qiuying Jiang; Chao Sun; ShiHao Liu; Zhikun Zhao; Dongfang Wu
Journal:  BMC Cancer       Date:  2022-02-21       Impact factor: 4.430

6.  Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours.

Authors:  Sally M Hunter; Genevieve V Dall; Maria A Doyle; Richard Lupat; Jason Li; Prue Allan; Simone M Rowley; David Bowtell; Ian G Campbell; Kylie L Gorringe
Journal:  BMC Res Notes       Date:  2020-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.